61 – 70 of 1422
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
2025) In Nature Medicine(
- Contribution to journal › Article
-
Mark
Updated appropriate use criteria for amyloid and tau PET : A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
(
- Contribution to journal › Scientific review
- 2024
-
Mark
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals
(
- Contribution to journal › Article
-
Mark
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Baseline Characteristics from Evoke and Evoke+ : Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer's Disease (P11-9.013)
(
- Contribution to journal › Published meeting abstract
-
Mark
IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease
2024) In Value in Health(
- Contribution to journal › Article
-
Mark
Unveiling the hippocampal subfield changes across the Alzheimer’s disease continuum : a systematic review of neuroimaging studies
(
- Contribution to journal › Scientific review
-
Mark
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
(
- Contribution to journal › Article
-
Mark
Associations of life-course cardiovascular risk factors with late-life cerebral haemodynamics
2024) In Journal of Cerebral Blood Flow and Metabolism(
- Contribution to journal › Article
-
Mark
Plasma p-tau immunoassays in clinical research for Alzheimer's disease
2024) In Alzheimer's and Dementia(
- Contribution to journal › Scientific review